6:35 PM
 | 
Dec 15, 2011
 |  BC Extra  |  Financial News

Ariad adds $224 million

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) raised $224 million through the sale of 21.5 million shares at $10.42 in a follow-on underwritten by JPMorgan; Cowen; Jefferies; BMO; Leerink; Oppenheimer; and...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >